This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Deijen, J.B. Articles by de Vries, J. Search for Related Content PubMed Articles by Deijen, J.B. Articles by de Vries, J. Social Bookmarking                         What's this?

Effects of paroxetine and maprotiline on mood, perceptual-motor skills and eye movements in healthy volunteers

Department of Psychology, Psychophysiology Division, Free University, Amsterdam, The Netherlands

S.M. Loriaux

Beecham Research Laboratories, Amstelveen, The Netherlands

J.F. Orlebeke

Department of Psychology, Psychophysiology Division, Free University, Amsterdam, The Netherlands

J. de Vries

Department of Psychology, Psychophysiology Division, Free University, Amsterdam, The Netherlands

Sixteen healthy young volunteers (seven females, nine males) received repeated doses of either 30 mg paroxetine, 100 mg maprotiline or placebo in a double-blind crossover study. Each of the three treatments lasted 1 week separated by 2 weeks of no treatment. Treatment order was counterbalanced. Subjects were tested before each treatment period, and after 1 and 7 days of treatment. Measurements were made of mood, perceptual-motor skills, and eye movements including pupil size when subjects were watching a traffic film.

Journal of Psychopharmacology, Vol. 3, No. 3, 149-155 (1989)
DOI: 10.1177/026988118900300305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. J. Goodnick and B. J. Goldstein Selective serotonin reuptake inhibitors in affective disorders -- I. Basic pharmacology J Psychopharmacol, January 1, 1998; 12(4_suppl): 5 - S20. [Abstract] [PDF]

				B. J. Goldstein and P. J Goodnick Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics J Psychopharmacol, January 1, 1998; 12(4_suppl): 55 - S87. [Abstract] [PDF]